P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 198 400 KRW -0.8% Market Closed
Market Cap: 2.1T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PharmaResearch Co Ltd
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Note Receivable
â‚©3.2B
CAGR 3-Years
8%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Note Receivable
â‚©78.2B
CAGR 3-Years
87%
CAGR 5-Years
50%
CAGR 10-Years
20%
SK Bioscience Co Ltd
KRX:302440
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Green Cross Corp
KRX:006280
Note Receivable
â‚©278.7m
CAGR 3-Years
-3%
CAGR 5-Years
41%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Note Receivable
â‚©827.5m
CAGR 3-Years
39%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

PharmaResearch Co Ltd
Glance View

Market Cap
2T KRW
Industry
Biotechnology

PharmaResearch Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology. The company is headquartered in Gangneung, Gangwon-Do. The company went IPO on 2015-07-24. The firm produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The firm mainly provides its products in domestic market.

Intrinsic Value
248 805.39 KRW
Undervaluation 20%
Intrinsic Value
Price
P

See Also

What is PharmaResearch Co Ltd's Note Receivable?
Note Receivable
3.2B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Note Receivable amounts to 3.2B KRW.

What is PharmaResearch Co Ltd's Note Receivable growth rate?
Note Receivable CAGR 5Y
22%

Over the last year, the Note Receivable growth was -26%. The average annual Note Receivable growth rates for PharmaResearch Co Ltd have been 8% over the past three years , 22% over the past five years .

Back to Top